P. Ron Ellis files SEC Form 4 disclosures for ENDOCYTE INC. They have made 1 open-market trade across 1 company since 2011, most recently 2016-06-24.
CIK 0001509418
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $15K since 2011, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ECYT | 320,040 | $7.7M |
Shares reported on the most recent Form 4, priced at the 2016-06-28 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ECYT | SELL · 10b5-1 | 2013-12-02 | 2013-12-04 | $12.00 | $36K | -24.6% | -0.5% | -0.5% |
| ECYT | SELL · 10b5-1 | 2013-11-06 | 2013-11-08 | $12.00 | $36K | -24.6% | -0.5% | -0.5% |
| ECYT | SELL · 10b5-1 | 2013-10-01 | 2013-10-02 | $13.30 | $40K | -24.6% | -0.5% | -0.5% |
| ECYT | SELL · 10b5-1 | 2013-09-03 | 2013-09-05 | $14.54 | $44K | -24.6% | -0.5% | -0.5% |
| ECYT | SELL · 10b5-1 | 2013-08-01 | 2013-08-06 | $18.12 | $54K | -24.6% | -0.5% | -0.5% |
| ECYT | SELL · 10b5-1 | 2013-07-15 | 2013-07-17 | $17.01 | $51K | -24.6% | -0.5% | -0.5% |
| ECYT | SELL · 10b5-1 | 2013-05-01 | 2013-05-03 | $13.88 | $7K | -24.6% | -0.5% | -0.5% |
| ECYT | SELL · 10b5-1 | 2013-04-01 | 2013-04-03 | $12.54 | $6K | -24.6% | -0.5% | -0.5% |
| ECYT | SELL · 10b5-1 | 2013-03-27 | 2013-03-29 | $12.00 | $18K | -24.6% | -0.5% | -0.5% |
| ECYT | SELL · 10b5-1 | 2012-12-31 | 2013-03-29 | $8.75 | $53K | -24.6% | -0.5% | -0.5% |
| ECYT | BUY | 2011-02-04 | 2011-02-08 | $6.00 | $15K | -24.6% | -0.5% | -0.5% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.